Jefferies analyst Peter Welford downgraded Novartis (NYSE: NVS) from Buy to Hold with a price target of $123.50.The analyst said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE